Clinical Trial Update: Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT [Phase 3]

View source ↗

Summary

Phase 3 Genetics Informatics Trial (GIFT) of warfarin to prevent deep vein thrombosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Thromboembolism | Phase 3 | Status: COMPLETED